Open Targets: a platform for therapeutic target identification and validation. - Gautier Koscielny; Peter An; Denise Carvalho-Silva; Jennifer A. Cham; Luca Fumis; Rippa Gasparyan; Samiul Hasan; Nikiforos Karamanis; Michael Maguire; Eliseo Papa; Andrea Pierleoni; Miguel Pignatelli; et al. (Nucleic Acids Res., 2017)

Open Targets Platform: new developments and updates two years on. - Denise Carvalho-Silva; Andrea Pierleoni; Miguel Pignatelli; Chuang Kee Ong; Luca Fumis; Nikiforos Karamanis; Miguel Carmona; Adam Faulconbridge; Andrew Hercules; Elaine McAuley; Alfredo Miranda; Gareth Peat; et al. (Nucleic Acids Res., 2019)

Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. - Maya Ghoussaini; Edward Mountjoy; Miguel Carmona; Gareth Peat; Ellen M. Schmidt; Andrew Hercules; Luca Fumis; Alfredo Miranda; Denise Carvalho-Silva; Annalisa Buniello; Tony Burdett; James D. Hayhurst; et al. (Nucleic Acids Res., 2021)

Open Targets Platform: supporting systematic drug-target identification and prioritisation. - David Ochoa; Andrew Hercules; Miguel Carmona; Daniel Suveges; Asier Gonzalez-Uriarte; Cinzia Malangone; Alfredo Miranda; Luca Fumis; Denise Carvalho-Silva; Michaela Spitzer; Jarrod Baker; Javier Ferrer; et al. (Nucleic Acids Res., 2021)

The next-generation Open Targets Platform: reimagined, redesigned, rebuilt. - David Ochoa; Andrew Hercules; Miguel Carmona; Daniel Suveges; Jarrod Baker; Cinzia Malangone; Irene Lopez; Alfredo Miranda; Carlos Cruz-Castillo; Luca Fumis; Manuel Bernal Llinares; Kirill Tsukanov; et al. (Nucleic Acids Res., 2023)